---
layout: post
title: April 2011 USANs
date: '2011-04-14T22:03:00.014+01:00'
author: John Overington
tags:
- INNS and USANS
modified_time: '2011-04-19T15:24:38.202+01:00'
thumbnail: http://3.bp.blogspot.com/_SlPG9DIz_AA/TRMbPgzd6CI/AAAAAAAAA9Y/DWPPmKSu7jg/s72-c/inns+and+usans.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-5138258507928474533
blogger_orig_url: http://chembl.blogspot.com/2011/04/april-2011-usans.html
---

<div class="separator" style="clear: both; text-align: center;"><a href="http://3.bp.blogspot.com/_SlPG9DIz_AA/TRMbPgzd6CI/AAAAAAAAA9Y/DWPPmKSu7jg/s1600/inns+and+usans.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="80" src="http://3.bp.blogspot.com/_SlPG9DIz_AA/TRMbPgzd6CI/AAAAAAAAA9Y/DWPPmKSu7jg/s320/inns+and+usans.png" style="cursor: move;" width="320" /></a></div>The March/April 2011 USANs have been published, these are:<br />
<br />
<table border="1"><tbody>
<tr><td><b>USAN </b></td><td><b>Research Code </b></td><td><b>Structure</b></td><td><b>Drug Type </b></td><td><b>Drug Class </b></td><td><b>Target </b></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/abexinostat.pdf">abexinostat</a>, <a href="http://www.ama-assn.org/resources/doc/usan/abexinostat-hydrochloride.pdf">abexinostat hydrochloride </a></td><td>PCI-24781, S-78454, PCI-24781-01, S-78454-1, CRA-024781-HCl, CRA-024781-01</td><td><div class="separator" style="clear: both; text-align: center;"><a href="http://2.bp.blogspot.com/-CxuAozSHUJw/Ta2VBY-3xaI/AAAAAAAABDs/Bilcn9G6dJ4/s1600/abexinostat.png" imageanchor="1"><img border="0" src="http://2.bp.blogspot.com/-CxuAozSHUJw/Ta2VBY-3xaI/AAAAAAAABDs/Bilcn9G6dJ4/s1600/abexinostat.png" /></a></div><div class="separator" style="clear: both; text-align: center;"></div><br />
</td><td>synthetic small molecule </td><td>therapeutic </td><td>HDAC </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/anivamersen.pdf">anivamersen</a>, <a href="http://www.ama-assn.org/resources/doc/usan/anivamersen-sodium.pdf">anivamersen sodium</a> </td><td>RB-007 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://2.bp.blogspot.com/-LFCQzmH7t48/Ta2VPJFctNI/AAAAAAAABD0/BUCUQB46dQE/s1600/anivamersen.png" imageanchor="1"><img border="0" src="http://2.bp.blogspot.com/-LFCQzmH7t48/Ta2VPJFctNI/AAAAAAAABD0/BUCUQB46dQE/s1600/anivamersen.png" style="cursor: move;" /></a></span></td><td>oligonucleotide </td><td>therapeutic  </td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/brodalumab.pdf">brodalumab </a></td><td>AMG-827 </td><td></td><td>monoclonal antibody </td><td>therapeutic </td><td>IL-17RA </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/cabozantinib.pdf">cabozantinib</a>, <a href="http://www.ama-assn.org/resources/doc/usan/cabozantinib-s-malate.pdf">cabozantinib s-malate </a></td><td>XL-184, BMS-907351 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://2.bp.blogspot.com/-E1S0UnbrerM/Ta2VZbUnAUI/AAAAAAAABD4/u3IxPaH-glg/s1600/cabozantinib.png" imageanchor="1"><img border="0" src="http://2.bp.blogspot.com/-E1S0UnbrerM/Ta2VZbUnAUI/AAAAAAAABD4/u3IxPaH-glg/s1600/cabozantinib.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic </td><td>MET RET VEGFR1 VEGFR2 VEGFR3 </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/calaspargase-pegol.pdf">calaspargase pegol </a></td><td>EZN-2285 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://4.bp.blogspot.com/-VmTQWLVXBmo/Ta2VqJfTzcI/AAAAAAAABD8/_rOoCdPa9Dk/s1600/calaspargase.png" imageanchor="1"><img border="0" src="http://4.bp.blogspot.com/-VmTQWLVXBmo/Ta2VqJfTzcI/AAAAAAAABD8/_rOoCdPa9Dk/s1600/calaspargase.png" style="cursor: move;" /></a></span></td><td>enzyme </td><td>therapeutic </td><td>- </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/cantuzumab-ravtansine.pdf">cantuzumab ravtansine </a></td><td>huC242-DM4, IMGN-242 </td><td></td><td>monoclonal antibody conjugate </td><td>therapeutic </td><td>mucin CanAg </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/cenderitide.pdf">cenderetide </a></td><td>CD-NP </td><td></td><td>peptide </td><td>therapeutic </td><td>NPRB </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/crenolanib.pdf">crenolanib </a></td><td>ARO-002; CP-868,596 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://3.bp.blogspot.com/-gWkPyZRtoQA/Ta2VzuMyGAI/AAAAAAAABEA/YwcfnFwOFlU/s1600/crenolanib.png" imageanchor="1"><img border="0" src="http://3.bp.blogspot.com/-gWkPyZRtoQA/Ta2VzuMyGAI/AAAAAAAABEA/YwcfnFwOFlU/s1600/crenolanib.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic </td><td>PDGFR </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/dabrafenib.pdf">dabrafenib</a>, <a href="http://www.ama-assn.org/resources/doc/usan/dabrafenib-mesylate.pdf">dabrafenib mesylate </a></td><td>GSK-2118436A </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://3.bp.blogspot.com/-XXLgfXXXlYw/Ta2V6YNzTPI/AAAAAAAABEE/iEmu70mNe5I/s1600/dabrafenib.png" imageanchor="1" ><img border="0" src="http://3.bp.blogspot.com/-XXLgfXXXlYw/Ta2V6YNzTPI/AAAAAAAABEE/iEmu70mNe5I/s1600/dabrafenib.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic </td><td>MEK </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/daclatasvir.pdf">daclatasvir</a>, <a href="http://www.ama-assn.org/resources/doc/usan/daclatasvir-dihydrochloride.pdf">daclatasvir dihydrochloride </a></td><td>BMS-790052 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://4.bp.blogspot.com/-_dHdzuOkduU/Ta2V_kklStI/AAAAAAAABEI/Ei9ukdvAA0Y/s1600/daclatasavir.png" imageanchor="1"><img border="0" src="http://4.bp.blogspot.com/-_dHdzuOkduU/Ta2V_kklStI/AAAAAAAABEI/Ei9ukdvAA0Y/s1600/daclatasavir.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic </td><td>HCV NS5A </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/dacomitinib.pdf">dacomitinib </a></td><td>PF-00299804-03 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://1.bp.blogspot.com/-YCrM09qeq-4/Ta2WF6jQkOI/AAAAAAAABEM/zg7YTQimmgo/s1600/dacomitinib.png" imageanchor="1"><img border="0" src="http://1.bp.blogspot.com/-YCrM09qeq-4/Ta2WF6jQkOI/AAAAAAAABEM/zg7YTQimmgo/s1600/dacomitinib.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic </td><td>EGFR, HER2 </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/dasolampanel.pdf">dasolampanel </a></td><td></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://3.bp.blogspot.com/-FogJXyI0tZY/Ta2WLqXXHHI/AAAAAAAABEQ/A7QcOh0WdB4/s1600/dasolampanel.png" imageanchor="1"><img border="0" src="http://3.bp.blogspot.com/-FogJXyI0tZY/Ta2WLqXXHHI/AAAAAAAABEQ/A7QcOh0WdB4/s1600/dasolampanel.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic </td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/delanzomib.pdf">delanzomib </a></td><td>CEP-18770, CT-47098, NPH-007098 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://4.bp.blogspot.com/-xJyWpH74ozw/Ta2WSFg87WI/AAAAAAAABEU/OTDiB7VClxk/s1600/delanzomib.png" imageanchor="1"><img border="0" src="http://4.bp.blogspot.com/-xJyWpH74ozw/Ta2WSFg87WI/AAAAAAAABEU/OTDiB7VClxk/s1600/delanzomib.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic </td><td>Proteosome </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/dolutegravir.pdf">dolutegravir</a>, <a href="http://www.ama-assn.org/resources/doc/usan/dolutegravir-sodium.pdf">dolutegravir sodium </a></td><td>GSK-1349572, S-349572, GSK-1349572A </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://2.bp.blogspot.com/-BG7UFELnpvM/Ta2WYHEhFyI/AAAAAAAABEY/t5c-nb8n9Sg/s1600/dolutegravir.png" imageanchor="1"><img border="0" src="http://2.bp.blogspot.com/-BG7UFELnpvM/Ta2WYHEhFyI/AAAAAAAABEY/t5c-nb8n9Sg/s1600/dolutegravir.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic </td><td>HIV-1 integrase </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/encaleret.pdf">encaleret</a>, <a href="http://www.ama-assn.org/resources/doc/usan/encaleret-sulfate.pdf">encaleret sulfate</a></td><td></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://3.bp.blogspot.com/-_KdwQsv0vow/Ta2WdfjUcxI/AAAAAAAABEc/vX7QCk39WSg/s1600/encaleret.png" imageanchor="1"><img border="0" src="http://3.bp.blogspot.com/-_KdwQsv0vow/Ta2WdfjUcxI/AAAAAAAABEc/vX7QCk39WSg/s1600/encaleret.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic  </td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/fiboflapon.pdf">fiboflapon</a>, <a href="http://www.ama-assn.org/resources/doc/usan/fiboflapon-sodium.pdf">fiboflapon sodium </a></td><td>GSK-2190915A, GSK-2190915B </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://4.bp.blogspot.com/-nyhojM06NEM/Ta2WjQ-mdgI/AAAAAAAABEg/ZY3mLgMWHPc/s1600/fiboflapon.png" imageanchor="1"><img border="0" src="http://4.bp.blogspot.com/-nyhojM06NEM/Ta2WjQ-mdgI/AAAAAAAABEg/ZY3mLgMWHPc/s1600/fiboflapon.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic </td><td>FLAP </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/iofolastat-i-123.pdf">iofolastat I123 </a></td><td>MIP-1072 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://2.bp.blogspot.com/-pgPPIVv2t6E/Ta2Wo4rj-HI/AAAAAAAABEk/DdxQilhLGhQ/s1600/iofolastat.png" imageanchor="1"><img border="0" src="http://2.bp.blogspot.com/-pgPPIVv2t6E/Ta2Wo4rj-HI/AAAAAAAABEk/DdxQilhLGhQ/s1600/iofolastat.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>diagnostic </td><td>PSMA</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/irdabisant.pdf">irdabisant </a></td><td>CEP-26401 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://2.bp.blogspot.com/-zejGWQ724WM/Ta2Wt9eByZI/AAAAAAAABEo/G7v-ufNdR-Q/s1600/irdabisant.png" imageanchor="1"><img border="0" src="http://2.bp.blogspot.com/-zejGWQ724WM/Ta2Wt9eByZI/AAAAAAAABEo/G7v-ufNdR-Q/s1600/irdabisant.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic </td><td>H3 </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/ixekizumab.pdf">ixekizumab </a></td><td>LY-2439821 </td><td></td><td>monoclonal antibody </td><td>therapeutic </td><td>IL-17A </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/levomilnacipran.pdf">levomilnacipran</a>, <a href="http://www.ama-assn.org/resources/doc/usan/levomilnacipran-hydrochloride.pdf">levomilnacipran hydrochloride </a></td><td>F-2695 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://3.bp.blogspot.com/-uUG2v4JED3o/Ta2WzTzVNwI/AAAAAAAABEs/aHB62L3xLXg/s1600/levomilnacipran.png" imageanchor="1"><img border="0" src="http://3.bp.blogspot.com/-uUG2v4JED3o/Ta2WzTzVNwI/AAAAAAAABEs/aHB62L3xLXg/s1600/levomilnacipran.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic </td><td>NET SET </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/lexibulin.pdf">lexibulin </a></td><td>CYT-997 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://1.bp.blogspot.com/-tBcm4qzAkOM/Ta2W6gLzvJI/AAAAAAAABEw/gkEsluGiNcU/s1600/lexibulin.png" imageanchor="1"><img border="0" src="http://1.bp.blogspot.com/-tBcm4qzAkOM/Ta2W6gLzvJI/AAAAAAAABEw/gkEsluGiNcU/s1600/lexibulin.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic</td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/lumacaftor.pdf">lumacaftor </a></td><td>VX-809, VRT-826809 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://1.bp.blogspot.com/-31XsbqmQYS4/Ta2XFz_R2OI/AAAAAAAABE0/ateI2PNqhiE/s1600/lumacaftor.png" imageanchor="1"><img border="0" src="http://1.bp.blogspot.com/-31XsbqmQYS4/Ta2XFz_R2OI/AAAAAAAABE0/ateI2PNqhiE/s1600/lumacaftor.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic</td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/narnatumab.pdf">narnatumab </a></td><td>IMC-RON8, IMC RON-8, RON8 </td><td></td><td>monoclonal antibody </td><td>therapeutic </td><td>RON </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/navarixin.pdf">navarixin </a></td><td>SCH-527123 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://2.bp.blogspot.com/-iIdlbyXk0Uo/Ta2XMN1erlI/AAAAAAAABE4/5EVtIzi2K0k/s1600/navarixin.png" imageanchor="1"><img border="0" src="http://2.bp.blogspot.com/-iIdlbyXk0Uo/Ta2XMN1erlI/AAAAAAAABE4/5EVtIzi2K0k/s1600/navarixin.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic </td><td>CXCR1, CXCR2 </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/olcorolimus.pdf">olcorolimus </a></td><td>SAR-943, SAR-943N, SAR-943-NXA, SDZ-227-943N </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://3.bp.blogspot.com/-nVG7nQc-hjc/Ta2XTH8KNLI/AAAAAAAABE8/X9Lq8eVGx2c/s1600/olcorolimus.png" imageanchor="1"><img border="0" src="http://3.bp.blogspot.com/-nVG7nQc-hjc/Ta2XTH8KNLI/AAAAAAAABE8/X9Lq8eVGx2c/s1600/olcorolimus.png" style="cursor: move;" /></a></span></td><td>natural product-derived small molecule </td><td>therapeutic </td><td>FKBP-12 </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/pegadricase.pdf">pegadricase </a></td><td>Uricase-PEG 20 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://3.bp.blogspot.com/-rEYhwyCcICc/Ta2XbLunG5I/AAAAAAAABFA/swtiPKL6q3M/s1600/pegadricase.png" imageanchor="1"><img border="0" src="http://3.bp.blogspot.com/-rEYhwyCcICc/Ta2XbLunG5I/AAAAAAAABFA/swtiPKL6q3M/s1600/pegadricase.png" style="cursor: move;" /></a></span></td><td>enzyme </td><td>therapeutic </td><td>-</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/peginterferon-lambda-1a.pdf">peginterferon lambda-1a </a></td><td>PEG-IL-29, PEG-rIL-29 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://1.bp.blogspot.com/-kUUctBktNsU/Ta2XhVxBU6I/AAAAAAAABFE/tS4v7rsXphY/s1600/peginterferon-lambda.png" imageanchor="1"><img border="0" src="http://1.bp.blogspot.com/-kUUctBktNsU/Ta2XhVxBU6I/AAAAAAAABFE/tS4v7rsXphY/s1600/peginterferon-lambda.png" style="cursor: move;" /></a></span></td><td>protein </td><td>therapeutic </td><td>IL28RA </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/pegnivacogin.pdf">pegnivacogin</a>, <a href="http://www.ama-assn.org/resources/doc/usan/pegnivacogin-sodium.pdf">pegnivacogin sodium </a></td><td>RB-006 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://1.bp.blogspot.com/-6PgwpiDQK2A/Ta2Xot0ejyI/AAAAAAAABFI/c7hAAhARoNU/s1600/pegnivacogin.png" imageanchor="1"><img border="0" src="http://1.bp.blogspot.com/-6PgwpiDQK2A/Ta2Xot0ejyI/AAAAAAAABFI/c7hAAhARoNU/s1600/pegnivacogin.png" style="cursor: move;" /></a></span></td><td>oligonucleotide </td><td>therapeutic  </td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/rucaparib.pdf">rucaparib</a>, <a href="http://www.ama-assn.org/resources/doc/usan/rucaparib-phosphate.pdf">rucaparib phosphate </a></td><td>AG-14699, AG-014699, PF-01367338, AG-14447 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://2.bp.blogspot.com/-uuhDnIxOyAc/Ta2XvbprmxI/AAAAAAAABFM/R2y7F-GmCAY/s1600/rucaparib.png" imageanchor="1"><img border="0" src="http://2.bp.blogspot.com/-uuhDnIxOyAc/Ta2XvbprmxI/AAAAAAAABFM/R2y7F-GmCAY/s1600/rucaparib.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic </td><td>PARP </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/sepantronium-bromide.pdf">sepantronium bromide </a></td><td>YM-155 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://2.bp.blogspot.com/-3oA3z2wSJRg/Ta2YwuTXkbI/AAAAAAAABFg/D_AiSqb79Z8/s1600/sepantronium-bromide.png" imageanchor="1"><img border="0" src="http://2.bp.blogspot.com/-3oA3z2wSJRg/Ta2YwuTXkbI/AAAAAAAABFg/D_AiSqb79Z8/s1600/sepantronium-bromide.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic </td><td>BIRC5 </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/simeprevir.pdf">simeprevir </a></td><td>TMC-435; TMC-435350 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://1.bp.blogspot.com/-HNPxPrFCWVs/Ta2Yq3JyLtI/AAAAAAAABFc/dnnfESjcNJk/s1600/simeprevir.png" imageanchor="1"><img border="0" src="http://1.bp.blogspot.com/-HNPxPrFCWVs/Ta2Yq3JyLtI/AAAAAAAABFc/dnnfESjcNJk/s1600/simeprevir.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic </td><td>HCV NS3/4A </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/sirukumab.pdf">sirukumab </a></td><td>CNTO-136 </td><td></td><td>monoclonal antibody </td><td>therapeutic </td><td>IL-6 </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/suvorexant.pdf">suvorexant </a></td><td>MK-4305 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://4.bp.blogspot.com/-UFg85ehc6E8/Ta2YUTCXd7I/AAAAAAAABFQ/-EgvfepdtMs/s1600/suvorexant.png" imageanchor="1"><img border="0" src="http://4.bp.blogspot.com/-UFg85ehc6E8/Ta2YUTCXd7I/AAAAAAAABFQ/-EgvfepdtMs/s1600/suvorexant.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic </td><td>OX1 OX2 </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/tabalumab.pdf">tabalumab </a></td><td>LY-2127399 </td><td></td><td>monoclonal antibody </td><td>therapeutic </td><td>BAFF </td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/technetium-tc-99m-tilmanocept.pdf">technetium 99m tilmanocept </a></td><td>1600 </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://1.bp.blogspot.com/-iX4ljMAnyhQ/Ta2YazwfJZI/AAAAAAAABFU/vtKHnTqU7JI/s1600/technicium.png" imageanchor="1"><img border="0" src="http://1.bp.blogspot.com/-iX4ljMAnyhQ/Ta2YazwfJZI/AAAAAAAABFU/vtKHnTqU7JI/s1600/technicium.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>diagnostic </td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/tofacitinib.pdf">tofacitinib </a></td><td>CP-690550, tasocitinib </td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://4.bp.blogspot.com/-yzQTiS33jOo/Ta2YgZ0nZfI/AAAAAAAABFY/kJlcxZUijfg/s1600/tofacitinib.png" imageanchor="1"><img border="0" src="http://4.bp.blogspot.com/-yzQTiS33jOo/Ta2YgZ0nZfI/AAAAAAAABFY/kJlcxZUijfg/s1600/tofacitinib.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule </td><td>therapeutic </td><td>JAK3 </td></tr>
</tbody></table><br />
As I get a few moments, I'll add the missing links and structures.... Sorry the structures are goofy.<br />
<br />
<table border="1" style="text-align: left;"><tbody>
<tr><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"><b>Drug Type</b></div></td><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"><b>Number</b></div></td></tr>
<tr><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;">synthetic small molecule</div></td><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;">31</div></td></tr>
<tr><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;">natural product derived small molecule</div></td><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;">1</div></td></tr>
<tr><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;">protein</div></td><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;">1</div></td></tr>
<tr><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;">peptide</div></td><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;">1</div></td></tr>
<tr><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;">monoclonal antibody</div></td><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;">7</div></td></tr>
<tr><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;">enzyme</div></td><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;">2</div></td></tr>
<tr><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;">oligonucleotide</div></td><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;">2</div></td></tr>
<tr><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"><b>Cumulative total for 2011</b></div></td><td><div style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;"><b>45</b></div></td></tr>
</tbody><tbody></tbody></table>